Who is Investing in Biotech Today? Kris Jenner (1/3)

Description

You're Watching:

Who is Investing in Biotech Today? Kris Jenner - Part 1

Marina Bozilenko interviews Dr. Kris Jenner of T. Rowe Price. What is the mood this year at the J.P. Morgan Healthcare Conference? What business models are investors looking for nowadays? How is the tone cautiously optimistic? Who is investing in Biotech today? Are we looking at the "core 100" or has the base expanded?

This interview was conducted at the JP Morgan Conference, on January 11th, 2010, in San Francisco.

Featuring:

  • Dr. Kris Jenner, Portfolio Manager, T. Rowe Price
  • Marina Bozilenko, Executive Producer, BioBusiness.TV

DISCLAIMER: VIEWERS SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

Reviews

Login or register to write a review

Related Videos

Reconsidering Small and Mid Caps, IPOs, and Value Drivers. Kris Jenner (2/3)

Reconsidering Small and Mid Caps, IPOs, and Value Drivers. Kris Jenner (2/3) ()

<markets>

Are small and mid-cap Biotech companies now being favored by investors? Many IPO have been filed; what will make T. Rowe buy? What will be driving the value of biotechnology stocks in 2010? An interview of Dr. Kris Jenner of T. Rowe Price, by Marina Bozilenko.

 

Reconsidering Small and Mid Caps, IPOs, and Value Drivers. Kr...

Shareholder Activism in 2010, Good or Bad? Kris Jenner (3/3)

Shareholder Activism in 2010, Good or Bad? Kris Jenner (3/3) ()

<markets>

Will shareholder activism increase this year? How will that affect Biotech? What are your market predictions for 2010? An interview of Dr. Kris Jenner of T. Rowe Price, by Marina Bozilenko.

 

Shareholder Activism in 2010, Good or Bad? Kris Jenner (3/3)

Subscribe